These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 19929715)

  • 1. Relevance of genetic polymorphisms in inflammatory response to percutaneous coronary intervention.
    Saleh N; Kovacs A; Tornvall P
    Scand J Clin Lab Invest; 2009; 69(7):736-40. PubMed ID: 19929715
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stent implantation, but not pathogen burden, is associated with plasma C-reactive protein and interleukin-6 levels after percutaneous coronary intervention in patients with stable angina pectoris.
    Saleh N; Svane B; Jensen J; Hansson LO; Nordin M; Tornvall P
    Am Heart J; 2005 May; 149(5):876-82. PubMed ID: 15894971
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship of interleukin-6-572C/G promoter polymorphism and serum levels to post-percutaneous coronary intervention restenosis.
    Gao J; Liu Y; Cui RZ; Mao YM; Zhou J; Chen Q; Zhao FM; Yang GM
    Chin Med J (Engl); 2013 Mar; 126(6):1019-25. PubMed ID: 23506572
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of inflammatory markers for the prediction of neointimal hyperplasia after drug-eluting stent implantation.
    Kang WC; Il Moon C; Lee K; Han SH; Suh SY; Moon J; Shin MS; Ahn T; Shin EK
    Coron Artery Dis; 2011 Dec; 22(8):526-32. PubMed ID: 21909023
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Percutaneous coronary intervention triggers a systemic inflammatory response in patients treated for in-stent restenosis -- comparison with stable and unstable angina.
    Kozinski M; Krzewina-Kowalska A; Kubica J; Zbikowska-Gotz M; Dymek G; Piasecki R; Sukiennik A; Grzesk G; Bogdan M; Chojnicki M; Dziedziczko A; Sypniewska G
    Inflamm Res; 2005 May; 54(5):187-93. PubMed ID: 15953990
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of percutaneous coronary intervention on the levels of interleukin-6 and C-reactive protein in the coronary circulation of subjects with coronary artery disease.
    Ramadan MM; Kodama M; Mitsuma W; Ito M; Kashimura T; Ikrar T; Hirono S; Okura Y; Aizawa Y
    Am J Cardiol; 2006 Oct; 98(7):915-7. PubMed ID: 16996873
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Different impacts of C-reactive protein and lipid profile on coronary lesions following a percutaneous coronary intervention.
    Xu HY; Qiao SB; Zhang JF; Dong QT; Li JJ
    Coron Artery Dis; 2012 May; 23(3):181-7. PubMed ID: 22336660
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the systemic levels of inflammatory markers after percutaneous coronary intervention with bare metal versus sirolimus-eluting stents.
    Rebeiz AG; Zoghbi E; Harb R; Youhanna S; Skouri HN; Dimassi A; Abou-Nader G; Nasrallah A; Sawaya J; Gharzuddine W; Alam S
    J Interv Cardiol; 2009 Apr; 22(2):169-74. PubMed ID: 19245380
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The increased plasma C-reactive protein and interleukin-6 levels in patients undergoing coronary artery bypass grafting surgery are associated with the interleukin-6-174G > C gene polymorphism.
    Wypasek E; Undas A; Sniezek-Maciejewska M; Kapelak B; Plicner D; Stepien E; Sadowski J
    Ann Clin Biochem; 2010 Jul; 47(Pt 4):343-9. PubMed ID: 20592333
    [TBL] [Abstract][Full Text] [Related]  

  • 10. C-reactive protein levels are influenced by common IL-1 gene variations.
    Berger P; McConnell JP; Nunn M; Kornman KS; Sorrell J; Stephenson K; Duff GW
    Cytokine; 2002 Feb; 17(4):171-4. PubMed ID: 11991668
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased C-reactive protein level after coronary stent implantation in patients with stable coronary artery disease.
    Almagor M; Keren A; Banai S
    Am Heart J; 2003 Feb; 145(2):248-53. PubMed ID: 12595841
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytokine response after percutaneous coronary intervention in stable angina: effect of selective glycoprotein IIb/IIIa receptor antagonism.
    Bonz AW; Lengenfelder B; Jacobs M; Strotmann J; Held S; Ertl G; Voelker W
    Am Heart J; 2003 Apr; 145(4):693-9. PubMed ID: 12679767
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Additive effect of interleukin-6 and C-reactive protein (CRP) single nucleotide polymorphism on serum CRP concentration and other cardiovascular risk factors.
    Paik JK; Kim OY; Koh SJ; Jang Y; Chae JS; Kim JY; Kim HJ; Hyun YJ; Cho JR; Lee JH
    Clin Chim Acta; 2007 May; 380(1-2):68-74. PubMed ID: 17335789
    [TBL] [Abstract][Full Text] [Related]  

  • 14. C-Reactive Protein and Inflammatory Cytokines during Percutaneous Coronary Intervention.
    Wu M; Gu X; Li X; Li Y; Zhou H; Lu G; Wu Z; Huang H; Tang L; Zeng J
    J Vasc Res; 2016; 53(1-2):39-48. PubMed ID: 27487299
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic variation in estrogen receptor, C-reactive protein and fibrinogen does not predict the plasma levels of inflammation markers after longterm hormone replacement therapy.
    de Maat MP; Madsen JS; Langdahl B; Bladbjerg EM; Tofteng CL; Abrahamsen B; Rejnmark L; Brixen K; Christensen K; Jespersen J; Kristensen SR
    Thromb Haemost; 2007 Feb; 97(2):234-9. PubMed ID: 17264952
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inflammatory response to coronary stent implantation in patients with unstable angina.
    Sánchez-Margalet V; Cubero JM; Martín-Romero C; Cubero J; Cruz-Fernández JM; Goberna R
    Clin Chem Lab Med; 2002 Aug; 40(8):769-74. PubMed ID: 12392302
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin 10: a new risk marker for the development of restenosis after percutaneous coronary intervention.
    Monraats PS; Kurreeman FA; Pons D; Sewgobind VD; de Vries FR; Zwinderman AH; de Maat MP; Doevendans PA; de Winter RJ; Tio RA; Waltenberger J; Huizinga TW; Eefting D; Quax PH; Frants RR; van der Laarse A; van der Wall EE; Jukema JW
    Genes Immun; 2007 Jan; 8(1):44-50. PubMed ID: 17122782
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic coronary angiography induces a systemic inflammatory response in patients with stable angina.
    Goldberg A; Zinder O; Zdorovyak A; Diamond E; Lischinsky S; Gruberg L; Markiewicz W; Beyar R; Aronson D
    Am Heart J; 2003 Nov; 146(5):819-23. PubMed ID: 14597930
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction between smoking and the interleukin-6 gene affects systemic levels of inflammatory biomarkers.
    Sunyer J; Forastiere F; Pekkanen J; Plana E; Kolz M; Pistelli R; Jacquemin B; Brüske-Hohlfeld I; Pitsavos Ch; Bellander T; Koenig W; Peters A;
    Nicotine Tob Res; 2009 Nov; 11(11):1347-53. PubMed ID: 19828434
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fatigued breast cancer survivors and gene polymorphisms in the inflammatory pathway.
    Reinertsen KV; Grenaker Alnæs GI; Landmark-Høyvik H; Loge JH; Wist E; Kristensen VN; Fosså SD; Edvardsen H
    Brain Behav Immun; 2011 Oct; 25(7):1376-83. PubMed ID: 21496483
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.